← Leaderboards
Feng Chen
Washington University
$14,745,479
Attributed
$21,464,966
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,964,965 · 12
By mechanism
U54$12,573,103 · 4
R01$8,624,414 · 5
U01$7,461,448 · 2
R21$306,000 · 1
Top collaborators
- Li Ding20 shared
- Ryan C Fields6 shared
- Sheila A Stewart5 shared
- Russell K. Pachynski2 shared
Most similar at Washington University
Same institution · by research overlap
- Sheng-Kwei Song$14,973,079
- Yong Wang$8,889,709
- Randall J Bateman$192,965,895
- Li Ding$30,836,856
- Dorothy Anne Cross$5,584,847
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTechnologyCellsResolutionGenesProteomicsTranscriptomicsTissuesGenomicsStructurePhenotypeAtlasesInfrastructureSignal TransductionMultiple OmicsImageGenome3-DimensionalMutationSamplingTumorLightMapsGenetic Transcription
Grant awards (44)
Human Prostate Tumor Atlas Center$4,130,083
U01 · FY2025 · CA
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2025 · AG
WU-SN-TMC Bio-Analysis Core$845,309
U54 · FY2025 · AG · contact PI
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment$475,364
R01 · FY2025 · CA
Creating high-resolution multi-omics molecular atlases for developing urogenital organs$446,539
U01 · FY2025 · DK · contact PI
Shared Resources Core$118,945
U54 · FY2025 · CA · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2024 · AG
Human Prostate Tumor Atlas Center$1,032,520
U01 · FY2024 · CA
WU-SN-TMC Bio-Analysis Core$836,427
U54 · FY2024 · AG · contact PI
Creating high-resolution multi-omics molecular atlases for developing urogenital organs$453,469
U01 · FY2024 · DK · contact PI
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment$451,596
R01 · FY2024 · CA
Shared Resources Core$112,860
U54 · FY2024 · CA · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2023 · AG
WU-SN-TMC Bio-Analysis Core$826,486
U54 · FY2023 · AG · contact PI
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment$468,852
R01 · FY2023 · CA
Creating high-resolution multi-omics molecular atlases for developing urogenital organs$460,084
U01 · FY2023 · DK · contact PI
Shared Resources Core$139,952
U54 · FY2023 · CA · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,499,999
U54 · FY2022 · AG
WU-SN-TMC Bio-Analysis Core$1,256,356
U54 · FY2022 · AG · contact PI
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment$481,478
R01 · FY2022 · CA
Creating high-resolution multi-omics molecular atlases for developing urogenital organs$466,384
U01 · FY2022 · DK · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2021 · AG
WU-SN-TMC Bio-Analysis Core$936,769
U54 · FY2021 · AG · contact PI
Creating high-resolution multi-omics molecular atlases for developing urogenital organs$472,369
U01 · FY2021 · DK · contact PI
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases$565,107
R01 · FY2020 · HG
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases$550,190
R01 · FY2019 · HG
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases$537,186
R01 · FY2018 · HG
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases$554,798
R01 · FY2017 · HG
NFAT SIGNALING IN GLOMERULOSCLEROSIS$312,246
R01 · FY2014 · DK · contact PI
NFAT SIGNALING IN GLOMERULOSCLEROSIS$301,317
R01 · FY2013 · DK · contact PI
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS$324,021
R01 · FY2012 · DK · contact PI
NFAT SIGNALING IN GLOMERULOSCLEROSIS$312,246
R01 · FY2012 · DK · contact PI
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS$324,021
R01 · FY2011 · DK · contact PI
NFAT SIGNALING IN GLOMERULOSCLEROSIS$312,246
R01 · FY2011 · DK · contact PI
NFAT SIGNALING IN GLOMERULOSCLEROSIS$380,000
R01 · FY2010 · DK · contact PI
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS$361,152
R01 · FY2010 · DK · contact PI
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS$364,800
R01 · FY2009 · DK · contact PI
Calcineurin in Congenital Urinary Tract Obstruction$300,691
R01 · FY2009 · DK · contact PI
Calcineurin in Congenital Urinary Tract Obstruction$300,690
R01 · FY2008 · DK · contact PI
Calcineurin in Congenital Urinary Tract Obstruction$306,827
R01 · FY2007 · DK · contact PI
Calcineurin in Congenital Urinary Tract Obstruction$315,991
R01 · FY2006 · DK · contact PI
Calcineurin in Congenital Urinary Tract Obstruction$323,595
R01 · FY2005 · DK
Calcineurin in Congenital Nephropathy$153,000
R21 · FY2004 · DK
Calcineurin in Congenital Nephropathy$153,000
R21 · FY2003 · DK